Masimo Corporation (MASI)
NASDAQ·Healthcare·Medical - Instruments & Supplies
$178.45
-0.12%
Mkt Cap $9.34B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $408.02M | $412.50M | +1.10% | $1.48 | $0.18 | -87.84% | — | — |
| Q4 2025 Nov 4, 2025 | $407.59M | $371.50M | -8.86% | $1.19 | $1.32 | +10.92% | — | — |
| Q3 2025 Aug 5, 2025 | $368.96M | $370.90M | +0.53% | $1.23 | $1.33 | +8.13% | — | — |
| Q2 2025 May 6, 2025 | $367.79M | $372.00M | +1.14% | $1.24 | $1.36 | +9.68% | — | — |
| Q1 2025 Feb 25, 2025 | $593.35M | $600.70M | +1.24% | $1.42 | $1.80 | +26.76% | — | — |
| Q4 2024 Nov 5, 2024 | $502.87M | $504.60M | +0.34% | $0.84 | $0.98 | +17.08% | — | — |
| Q3 2024 Aug 6, 2024 | $493.56M | $496.30M | +0.56% | $0.77 | $0.86 | +11.69% | — | — |
| Q2 2024 May 7, 2024 | $487.55M | $492.80M | +1.08% | $0.71 | $0.77 | +8.45% | — | — |
| Q1 2024 Feb 27, 2024 | $545.73M | $548.90M | +0.58% | $0.95 | $1.25 | +31.58% | — | — |
| Q4 2023 Nov 7, 2023 | $536.91M | $478.90M | -10.80% | $0.59 | $0.63 | +6.78% | — | — |
| Q3 2023 Aug 8, 2023 | $478.35M | $455.30M | -4.82% | $0.86 | $0.62 | -27.91% | — | — |
| Q2 2023 May 9, 2023 | $558.74M | $565.00M | +1.12% | $0.83 | $0.87 | +4.82% | — | — |
| Q1 2023 Feb 28, 2023 | $602.49M | $2.04B | +237.90% | $1.17 | $1.32 | +12.82% | — | — |
| Q4 2022 Nov 8, 2022 | $534.88M | $549.30M | +2.70% | $0.92 | $1.00 | +8.70% | — | — |
| Q3 2022 Aug 9, 2022 | $540.57M | $565.30M | +4.58% | $1.19 | $1.35 | +13.45% | — | — |
| Q2 2022 May 3, 2022 | $308.04M | $304.24M | -1.23% | $0.87 | $0.93 | +6.90% | — | — |
| Q1 2022 Feb 15, 2022 | $320.52M | $327.58M | +2.20% | $1.10 | $1.21 | +10.00% | — | — |
| Q4 2021 Oct 26, 2021 | $295.79M | $307.41M | +3.93% | $0.91 | $0.94 | +3.30% | — | — |
| Q3 2021 Jul 27, 2021 | $295.79M | $305.12M | +3.15% | $0.90 | $0.94 | +4.44% | — | — |
| Q2 2021 Apr 26, 2021 | $296.21M | $299.04M | +0.96% | $0.88 | $0.90 | +2.27% | — | — |